The Current Ratio as of September 2024 (TTM) for Avadel Pharmaceuticals plc (AVDL) is 2.82

According to Avadel Pharmaceuticals plc’s latest financial reports and current stock price. The company's current Current Ratio is 2.82. This represents a change of -9.73% compared to the average of 3.12 of the last 4 quarters.

Avadel Pharmaceuticals plc (AVDL) Historical Current Ratio (quarterly & annually)

How has AVDL Current Ratio performed in the past?

The mean historical Current Ratio of Avadel Pharmaceuticals plc over the last ten years is 4.69. The current 2.82 Current Ratio has changed 5.91% with respect to the historical average. Over the past ten years (40 quarters), AVDL's Current Ratio was at its highest in in the March 2021 quarter at 26.57. The Current Ratio was at its lowest in in the September 2015 quarter at 0.

Avadel Pharmaceuticals plc (AVDL) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Avadel Pharmaceuticals plc Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Avadel Pharmaceuticals plc (AVDL) Average Current Ratio

How has AVDL Current Ratio performed in the past?

The current Current Ratio of Avadel Pharmaceuticals plc (AVDL) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Avadel Pharmaceuticals plc (AVDL) Current Ratio vs. Peers

How is AVDL’s Current Ratio compared to its peers?

Avadel Pharmaceuticals plc’s Current Ratio is less than Neurocrine Biosciences, Inc. (4.19), less than Deciphera Pharmaceuticals, Inc. (4.19), less than Ironwood Pharmaceuticals, Inc. (3.92), less than Alkermes plc (2.99), less than Intra-Cellular Therapies, Inc. (7.81), less than Dynavax Technologies Corporation (14.18), greater than Journey Medical Corporation (1.36), greater than Evoke Pharma, Inc. (1.28), greater than Jupiter Wellness, Inc. (1.92), less than Aquestive Therapeutics, Inc. (7.49), greater than Eagle Pharmaceuticals, Inc. (2.16), less than ANI Pharmaceuticals, Inc. (3.97), greater than Agile Therapeutics, Inc. (0.55), greater than Assertio Holdings, Inc. (1.93), greater than Amneal Pharmaceuticals, Inc. (1.33), less than AcelRx Pharmaceuticals, Inc. (4.04), greater than Lifecore Biomedical, Inc. (2.08),

Build a custom stock screener for Avadel Pharmaceuticals plc (AVDL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Avadel Pharmaceuticals plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Avadel Pharmaceuticals plc (AVDL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Avadel Pharmaceuticals plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.